Can anti-inflammatory strategies light up the dim depression pipeline?

J&J's phase II trial of an immunomodulator for depression could inform the development of stratified medicine in psychiatry.

Search for this author in:

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Nature Reviews Drug Discovery 19, 224-225 (2020)

doi: 10.1038/d41573-020-00049-5

Nature Briefing

An essential round-up of science news, opinion and analysis, delivered to your inbox every weekday.